They've already paid off all of their debts. Bankruptcy isn't even in the cards. Worst case scenario is the company becomes insolvent and our shares become toilet paper. Given their proprietary MATCH technology, that won't happen. It's worth $1.50/share, minimum, without factoring the value of MATCH into it. BMY paid them 80M a piece for two trials using the MATCH tech. 80M is about 5 times this company's current market cap, so I'm fairly sure these shares are worth at least 5 times what they're currently trading at, if not double that (two trials at 80M a piece) ... 10 times. That'd be $5.40/share. I doubt that'll happen, but I can easily see $2/share.